--- title: "Pre-market hot trades in US stocks: Robinhood up 5.51% in pre-market; Zenta down 5.45% in pre-market" type: "News" locale: "en" url: "https://longbridge.com/en/news/296601624.md" description: "Robinhood pre-market up 5.51%; Zenta pre-market down 5.45%; RF Acquisition Corp II pre-market up 481.30%; RF ACQUISITION CORP II COM USD0.0001(S/R 15/02/2027) pre-market up 113.09%; Werewolf Therapeutics pre-market up 81.15%" datetime: "2026-08-21T10:07:38.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296601624.md) - [en](https://longbridge.com/en/news/296601624.md) - [zh-HK](https://longbridge.com/zh-HK/news/296601624.md) generator: "portal-rs" --- # Pre-market hot trades in US stocks: Robinhood up 5.51% in pre-market; Zenta down 5.45% in pre-market **Popular Pre-Market Trades in U.S. Stocks** Robinhood is up 5.51% in pre-market trading. Based on recent key news: 1. On August 20, Robinhood CEO Vlad Tenev called on U.S. regulators to remove barriers to the development of tokenized stocks, emphasizing that tokenization could bring advantages such as around-the-clock trading and real-time settlement. This news may have boosted market confidence in Robinhood's future development, driving the stock price up. 2. On August 20, Robinhood rose 5.77% in pre-market trading, reaching $101.30, showing a positive market reaction to its recent performance. According to data from Benzinga Pro, this increase may be related to optimistic expectations regarding its tokenized stock plans. 3. On August 19, Robinhood's stock price added approximately $3.24 billion in market value over the past week, reflecting increased market confidence in its long-term growth potential. The trend of tokenization is driving the development of around-the-clock trading. Zenta is down 5.45% in pre-market trading. There has been no significant news recently; trading is active with clear capital flows. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. no\_news **Top Gainers in U.S. Pre-Market Trading** RF Acquisition Corp II is up 481.30% in pre-market trading. Based on recent key news: 1. On August 20, RF Acquisition Corp II released its latest announcement through the EDGAR system, disclosing the company's financial and operational status. This announcement triggered a positive market reaction, significantly boosting the stock price. 2. On August 21, shareholders submitted a preliminary request to redeem 3.95 million shares of RFAC stock. This news increased market confidence in the company's future development, further driving the stock price up. 3. Over the past 12 months, RF Acquisition Corp II's stock price has risen by 19.98%, with the current trading price nearing its annual high. This indicates that the market holds an optimistic view of the company's prospects, leading to a sustained increase in stock price. The market is optimistic about SPAC companies, with clear capital inflows. RF ACQUISITION CORP II COM USD0.0001(S/R 15/02/2027) is up 113.09% in pre-market trading, with no significant news recently. Trading is active with clear capital flows, and considering sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation. Werewolf Therapeutics is up 81.15% in pre-market trading. Based on recent key news: 1. On August 20, Werewolf Therapeutics announced the sale of its inducers and Indukine platform to EMD Serono. According to SEC filings, EMD will pay $28 million in upfront payments and $5 million upon completion of the asset transfer This transaction brought significant cash inflow to the company, driving a substantial increase in stock price. 2. On August 20, Werewolf Therapeutics obtained exclusive development licenses for WTX-124 and WTX-330 from EMD. This license may enhance the company's competitiveness in the biopharmaceutical field, further boosting market confidence. 3. On August 20, Werewolf Therapeutics released relevant announcements through the EDGAR system to ensure information transparency and investor trust, further supporting the rise in stock price. The biopharmaceutical industry has seen active trading recently, with noticeable capital inflow ### Related Stocks - [HOOD.US](https://longbridge.com/en/quote/HOOD.US.md) - [ZTG.US](https://longbridge.com/en/quote/ZTG.US.md) - [RFAI.US](https://longbridge.com/en/quote/RFAI.US.md) - [RFAIR.US](https://longbridge.com/en/quote/RFAIR.US.md) - [HOWL.US](https://longbridge.com/en/quote/HOWL.US.md) ## Related News & Research - [Here's How Much $100 Invested In Robinhood Markets 5 Years Ago Would Be Worth Today](https://longbridge.com/en/news/296153115.md) - [What's Going On With Robinhood Markets Stock Thursday?](https://longbridge.com/en/news/296526882.md) - [Tria Adds Robinhood Chain Support, Bringing Tokenized Assets Into Everyday Spending](https://longbridge.com/en/news/296234566.md) - [Robinhood Is Fixing Its Biggest Weakness. HOOD Stock Could Keep Rising From Here.](https://longbridge.com/en/news/295688613.md) - [Robinhood Markets Inc Stock (HOOD) Moved Up by 12.39% on Aug 21: What Signal Does It Send?](https://longbridge.com/en/news/296629438.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**